Edward L. Posvar - Concepedia

Concepedia

Author

Edward L. Posvar

Pfizer (United States)

Also Known As

E Posvar, E. L. Posvar, Edward L Posvar, Edward L. Posvar, Edward Posvar

30

Publications

2.2K

Citations

19

H-Index

55

Concepts

All Affiliations

Pfizer (United States)Warner University Amgen (United States)Warde Medical Laboratory University of Michigan

EL

About

Edward L. Posvar is an author at Pfizer (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	968
2	Health Sciences	2	2	77
3	Social Sciences	2	2	38
4	Endocrinology	2	2	36
5	Immunology	1	1	776

Edward L. Posvar

×

26

Publications

2.2K

Citations

19

H-Index

	Year	Citations
Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody Desmond Padhi, Graham Jang, Brian Stouch, Journal of Bone and Mineral Research SclerostinHealthy SubjectsImmunologyPharmacotherapySclerostin Monoclonal Antibody	2010	776
Pharmacokinetics of Pregabalin in Subjects with Various Degrees of Renal Function Edward J. Randinitis, Edward L. Posvar, Christine Alvey, The Journal of Clinical Pharmacology	2003	251
Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects Donald D. Cilla, Lloyd R. Whitfield, Donald M. Gibson, Clinical Pharmacology & Therapeutics	1996	203
Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers Howard N. Bockbrader, Louis L. Radulovic, Edward L. Posvar, The Journal of Clinical Pharmacology	2010	182
Pregabalin Drug Interaction Studies: Lack of Effect on the Pharmacokinetics of Carbamazepine, Phenytoin, Lamotrigine, and Valproate in Patients with Partial Epilepsy Martin J. Brodie, Elaine A. Wilson, David Wesche, Epilepsia	2005	124
Tolerance and Pharmacokinetics of Single‐Dose Atorvastatin, a Potent Inhibitor of HMG‐CoA Reductase, in Healthy Subjects Edward L. Posvar, Louis L. Radulovic, Donald D. Cilla, The Journal of Clinical Pharmacology	1996	91
Single‐Dose Gabapentin Pharmacokinetics and Safety in Healthy Infants and Children George M. Haig, Howard N. Bockbrader, David Wesche, The Journal of Clinical Pharmacology	2001	83
Effect of Food on the Bioavailability of Atorvastatin, an HMG‐CoA Reductase Inhibitor Louis L. Radulovic, Donald D. Cilla, Edward L. Posvar, The Journal of Clinical Pharmacology	1995	61
Metabolic disposition of pregabalin in healthy volunteers Brian Corrigan, W F Pool, Edward L. Posvar, Clinical Pharmacology & Therapeutics Metabolic SyndromeNutritionEnergy MetabolismHealth SciencesMedicine	2001	58
Lack of Interaction of Gabapentin with Carbamazepine or Valproate Louis L. Radulovic, B. J. Wilder, Ilo E. Leppik, Epilepsia	1994	47

Page 1